111 (NASDAQ:YI – Get Free Report) and Cigna Group (NYSE:CI – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.
Volatility and Risk
111 has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500.
Profitability
This table compares 111 and Cigna Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 111 | -1.01% | N/A | -4.86% |
| Cigna Group | 2.27% | 19.75% | 5.34% |
Institutional & Insider Ownership
Valuation and Earnings
This table compares 111 and Cigna Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 111 | $1.80 billion | 0.02 | -$9.65 million | ($1.60) | -1.97 |
| Cigna Group | $274.90 billion | 0.27 | $5.96 billion | $24.17 | 11.68 |
Cigna Group has higher revenue and earnings than 111. 111 is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current recommendations and price targets for 111 and Cigna Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 111 | 1 | 0 | 0 | 0 | 1.00 |
| Cigna Group | 0 | 8 | 15 | 0 | 2.65 |
Cigna Group has a consensus target price of $338.24, indicating a potential upside of 19.84%. Given Cigna Group’s stronger consensus rating and higher probable upside, analysts clearly believe Cigna Group is more favorable than 111.
Summary
Cigna Group beats 111 on 12 of the 14 factors compared between the two stocks.
About 111
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
